Genetic Testing and Counseling Working Group
This Discussion Guide is the product of a multi-stakeholder Genetic Testing and Counseling working group convened by The ALS Association. The working group formed as follow-up of challenges identified in genetic testing and counseling during the spring 2020 ALS Roundtable meeting focusing on Reducing Time to Diagnosis.
Thank you to all our working group members for their time and talent to develop the ALS Genetic Discussion Guide.
The Genetic Testing and Counseling Working Group Members are:
- Dr. Jinsy Andrews, Columbia University Medical Center
- Dr. Michael Benatar, University of Miami
- Sellam Birhane, The ALS Association
- Kristina Bowyer, Ionis Pharmaceuticals
- Cathy Cummings, International Alliance for ALS/MND Associations
- Dr. Eleonore Dubois, Biogen
- Megan and Drew Duffy, ALS Focus Patient and Caregiver Advisory Committee Member
- Elizabeth Harrington, Columbia University Medical Center
- Dr. Steve Kolb, Ohio State University Medical Center
- Megan Murphy, Biogen
- Lora Polari-Welbes, ALS Focus Patient and Caregiver Advisory Committee Member
- Jennifer Roggenbuck, Ohio State University Medical Center
- John Russo, ALS Focus Patient and Caregiver Advisory Committee Member
- Wendy Selig, WSCollaborative
- Dr. Neil Thakur, The ALS Association
- Dr. David Weinstein, Apellis Pharmaceuticals
- Dr. Jill Yersak, The ALS Association